
DEPT
FACULTY
COVID-19 Contribution
01 Apr 2023
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is uncertain. Objective: To examine the real-world effectiveness of mo...Read more
01 Mar 2023
02 Dec 2022
Background: With accruing case reports on de novo or relapsing glomerular diseases (GD) following different severe acute respiratory syndrome coronavi...Read more
31 Dec 2022
Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited...Read more
08 Jun 2022
Background: Observable symptoms of Bell's palsy following vaccinations arouse concern over the safety profiles of novel coronavirus disease 2019 (COVI...Read more
17 May 2022
Importance: COVID-19 has required universities to rapidly develop vaccination policies for students and staff, yet little is known about the preferenc...Read more
27 Apr 2022
Objectives: The coronavirus-19 (COVID-19) pandemic has claimed more than 5 million lives worldwide by November 2021. Implementation of lockdown measur...Read more
01 Dec 2022
Background: Safety after the second dose of the SARS-CoV-2 vaccine remains to be elucidated, especially among individuals reporting adverse events aft...Read more
01 Nov 2021
01 Dec 2022
Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong
Prior research using electronic health records for Covid-19 vaccine safety monitoring typically focuses on specific disease groups and excludes indivi...Read more
31 Aug 2022
Young male BioNTech vaccine recipients have the highest risk of developing heart inflammation after their second Covid-19 jab, with more than 18 cases...Read more
03 May 2023
BACKGROUND: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where da...Read more
13 Jun 2023
IntroductionEvidence on long-term associations between COVID-19 and risks of multi-organ complications and mortality in older population is limited. T...Read more
03 Apr 2023
Extended intervals between the first and second doses of mRNA Covid-19 vaccines may reduce the risk of myocarditis in children and adolescents. Howeve...Read more
07 Mar 2022
Researchers from the Department of Pharmacology and Pharmacy of the LKS Faculty of Medicine at The University of Hong Kong found intramuscular olanzap...Read more
16 Dec 2022
Background Association between messenger RNA (mRNA) COVID-19 vaccines and myocarditis has aroused public concern over vaccine safety. Objectives Th...Read more
01 Dec 2022
Background: The World Health Organization has defined a list of adverse events of special interest (AESI) for safety surveillance of vaccines. AESI ha...Read more
01 Apr 2022
Several studies reported hematological abnormalities after vaccination against the coronavirus disease 2019 (COVID-19). We evaluated the association b...Read more
20 Oct 2021
27 Jul 2021